Medical comms - Press Releases

Date	Title	Company
10-Aug-2020	Biophytis Receives Approval from Brazilian Health Regulatory Agency to Start COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure	Biophytis SA
10-Aug-2020	Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)	Eli Lilly and Company
10-Aug-2020	Wockhardt announces COVID-19 vaccine partnership with UK Government	Wockhardt
10-Aug-2020	BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China	BioNTech SE
10-Aug-2020	Joint working between PCNs and mental health providers must accelerate in the aftermath of COVID-19	PCN Network
10-Aug-2020	CIMZIA® is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum	UCB
10-Aug-2020	Lundbeck discontinues phase II proof of concept study of Lu AF11167 in patients with negative symptoms of schizophrenia	H. Lundbeck A/S
10-Aug-2020	Fujifilm Selects Kinaxis RapidResponse for Agility in its Medical System Supply Chain	Kinaxis Inc
10-Aug-2020	Thermo Fisher Scientific Launches Exclusive Website for its Chemical Business Offerings in India	Thermo Fisher Scientific
10-Aug-2020	Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers	Clovis Oncology, Inc
10-Aug-2020	Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering	Tiziana Life Sciences plc (
10-Aug-2020	Vifor Pharma Group reports continued growth in H1 2020	Vifor Pharma Group
10-Aug-2020	Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL	Nordic Nanovector ASA
10-Aug-2020	CSL Behring to become latest partner in BaseLaunch Phase II	CSL Behring
10-Aug-2020	BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020	BioNTech SE
10-Aug-2020	Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis	Novartis
10-Aug-2020	Novartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps	Novartis
10-Aug-2020	Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL	Nordic Nanovector
10-Aug-2020	RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico	RedHill Biopharma
10-Aug-2020	New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19	Alliance for Regenerative Medicine